SERPINB4 and hepatocellular carcinoma: In patients with chronic hepatitis the serpinB4-IgM(SCC103)/serpinB3-IgM median ratio was 1.40 (range 1.0–4.5), in patients with cirrhosis it was 1.10 (range 0.9–6.2), and in patients with HCC it was 1.08 (range 0.4–4.2).